These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26757983)

  • 1. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.
    Togneri FS; Ward DG; Foster JM; Devall AJ; Wojtowicz P; Alyas S; Vasques FR; Oumie A; James ND; Cheng KK; Zeegers MP; Deshmukh N; O'Sullivan B; Taniere P; Spink KG; McMullan DJ; Griffiths M; Bryan RT
    Eur J Hum Genet; 2016 Aug; 24(8):1167-74. PubMed ID: 26757983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
    Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
    Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test].
    Léon P; Cancel Tassin G; Sighar K; Compérat E; Gaffory C; Ondet V; Hugonin S; Audouin M; Doizi S; Traxer O; Ciofu C; Rouprêt M; Lacave R; Cussenot O
    Prog Urol; 2017; 27(8-9):451-457. PubMed ID: 28576425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
    Ward DG; Gordon NS; Boucher RH; Pirrie SJ; Baxter L; Ott S; Silcock L; Whalley CM; Stockton JD; Beggs AD; Griffiths M; Abbotts B; Ijakipour H; Latheef FN; Robinson RA; White AJ; James ND; Zeegers MP; Cheng KK; Bryan RT
    BJU Int; 2019 Sep; 124(3):532-544. PubMed ID: 31077629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
    Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
    Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
    Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
    Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Detection of Urothelial Carcinoma by Cost-effective Low-coverage Whole-genome Sequencing from Urine-Exfoliated Cell DNA.
    Zeng S; Ying Y; Xing N; Wang B; Qian Z; Zhou Z; Zhang Z; Xu W; Wang H; Dai L; Gao L; Zhou T; Ji J; Xu C
    Clin Cancer Res; 2020 Nov; 26(21):5646-5654. PubMed ID: 33037018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
    Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
    J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
    Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
    Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.
    Linscott JA; Miyagi H; Murthy PB; Yao S; Grass GD; Vosoughi A; Xu H; Wang X; Yu X; Yu A; Zemp L; Gilbert SM; Poch MA; Sexton WJ; Spiess PE; Li R
    Curr Oncol Rep; 2024 Aug; 26(8):945-958. PubMed ID: 38837106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can urinary biomarkers replace cystoscopy?
    Maas M; Bedke J; Stenzl A; Todenhöfer T
    World J Urol; 2019 Sep; 37(9):1741-1749. PubMed ID: 30283995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.
    Rose KM; Huelster HL; Meeks JJ; Faltas BM; Sonpavde GP; Lerner SP; Ross JS; Spiess PE; Grass GD; Jain RK; Kamat AM; Vosoughi A; Wang L; Wang X; Li R
    Nat Rev Urol; 2023 Jul; 20(7):406-419. PubMed ID: 36977797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
    Hirotsu Y; Yokoyama H; Amemiya K; Hagimoto T; Daimon H; Hosaka K; Oyama T; Mochizuki H; Omata M
    Cancer Sci; 2019 Oct; 110(10):3235-3243. PubMed ID: 31368627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor.
    Bou Zerdan M; Bratslavsky G; Jacob J; Ross J; Huang R; Basnet A
    Mol Diagn Ther; 2023 Jul; 27(4):475-485. PubMed ID: 37195586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.